My LITECOIN Price Prediction for OCTOBER 2026
1 extracted signal · 0 resolved · 1 still active
Altcoin DoctorIndependent analyst profile- Source published
- 03 Oct 2026, 04:59 UTC
- Recorded by Tahlil Plus
- 03 Oct 2026, 06:31 UTC

AI-generated source summary
The analysis focuses on Litecoin (LTC) against the US Dollar (LTCUSD) on a weekly timeframe. The current price is observed to be around $69.56. A bullish prediction is made, with a target price of approximately $106.19. The fail bound, which would invalidate this bullish outlook, is set at $41.23. This level serves as a critical support. The broader market context is discussed through the USDT and TOTAL2 market cap charts. The USDT dominance chart shows a potential bearish trend, indicating a possible shift of funds into other cryptocurrencies. The TOTAL2 chart, representing the total crypto market cap excluding Bitcoin, shows a pattern suggesting a potential significant upward movement, reinforcing the bullish outlook for altcoins. The BTC.D chart indicates that Bitcoin dominance has been falling, which historically precedes altcoin season. The analysis suggests that as BTC.D falls and TOTAL2 rises, altcoins are expected to perform well.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Altcoin Doctor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
